SCHEMBL2132814

SCHEMBL2132814

CN1CCN([C@H]2CC[C@H](C(=O)O)CC2)C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 3/20 0.46
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ DUSP3 P51452 1/20 0.41
▸ POLB P06746 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ PDE7A Q13946 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.35
▸ LCK P06239 1/20 0.34
▸ JAK3 P52333 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ LMNA P02545 2/20 0.33
▸ NEK2 P51955 1/20 0.33
▸ PLG P00747 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL380733 1.00 NPY5R (0.46) NPY5RMEN1KMT2ADUSP3POLB
SCHEMBL2135137 1.00 NPY5R (0.46) NPY5RMEN1KMT2ADUSP3POLB
SCHEMBL401875 0.90 NPY5R (0.47) NPY5RMEN1KMT2ADUSP3POLB
SCHEMBL379628 0.90 NPY5R (0.47) NPY5RMEN1KMT2ADUSP3POLB
SCHEMBL13455119 0.85 NPY5R (0.41) NPY5RKMT2APDE7ALCKJAK3
SCHEMBL15878658 0.83 POLB (0.44) NPY5RMEN1KMT2ADUSP3POLB
SCHEMBL15878656 0.83 POLB (0.44) NPY5RMEN1KMT2ADUSP3POLB
SCHEMBL21222135 0.79 PDE7A (0.50) NPY5RPDE7AKDM4EALDH1A1LCK
SCHEMBL15448411 0.78 NPY5R (0.38) NPY5RPDE7AKDM4EALDH1A1NPSR1
SCHEMBL23714592 0.77 MAPK1 (0.43) NPY5RPDE7ALCKJAK3BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408767-B1 AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS LUNDBECK & CO AS H (DK) 2013-07-10 — — EP claimed
WO-2010108052-A2 AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS H. LUNDBECK A/S (DK) 2010-09-23 — — WO claimed
EP-2408767-B1 AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS LUNDBECK & CO AS H (DK) 2013-07-10 — — EP disclosed
US-20120101078-A1 AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS H. LUNDBRCK A/S (DK) 2012-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101078-A1 AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS NPY5R, NPY1R, NPY2R NPY5R 1/4885MEN1 4129/4885KMT2A 1750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback